aid: cr-bard
name: C. R. Bard
kind: company
description: >-
  C. R. Bard, Inc. was an American multinational developer, manufacturer, and
  marketer of medical technologies in the fields of vascular, urology, oncology,
  and surgical specialties. Bard was founded in 1907 by Charles Russell Bard and
  was acquired by Becton, Dickinson and Company (BD) in December 2017 for
  approximately $24 billion. Bard's product lines now operate as part of BD's
  Interventional segment under the BD Bard brand. No public API or developer
  portal is published; integrations with hospital and provider systems are
  arranged through BD enterprise channels.
image: https://kinlane-productions2.s3.amazonaws.com/apis-json/apis-json-logo.jpg
url: https://raw.githubusercontent.com/api-evangelist/cr-bard/refs/heads/main/apis.yml
type: Index
access: 3rd-Party
position: Consuming
created: '2024-01-01'
modified: '2026-04-28'
tags:
  - BD
  - Becton Dickinson
  - Interventional
  - Medical Devices
  - Medical Technology
  - Oncology
  - Surgery
  - Urology
  - Vascular
apis: []
common:
  - type: Website
    url: https://www.bd.com/en-us
  - type: BDBardBrand
    url: https://www.bd.com/en-us/products-and-solutions/products/product-brands/bard
  - type: LegacyWebsite
    url: https://www.crbard.com
  - type: BDInterventional
    url: https://www.bd.com/en-us/about-bd/our-businesses/bd-interventional
  - type: BDAcquisitionAnnouncement
    url: https://news.bd.com/2017-12-29-BD-Completes-Acquisition-of-C-R-Bard
  - type: ContactBD
    url: https://www.bd.com/en-us/about-bd/contact-us
  - type: BDLinkedIn
    url: https://www.linkedin.com/company/bd1/
  - type: PrivacyPolicy
    url: https://www.bd.com/en-us/about-bd/privacy-statement
  - type: TermsOfUse
    url: https://www.bd.com/en-us/about-bd/terms-of-use
maintainers:
  - FN: Kin Lane
    email: kin@apievangelist.com